Conversations About Financial Issues in Routine Oncology Practices: A Multicenter Study.
Journal
Journal of oncology practice
ISSN: 1935-469X
Titre abrégé: J Oncol Pract
Pays: United States
ID NLM: 101261852
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
pubmed:
5
6
2019
medline:
8
8
2020
entrez:
5
6
2019
Statut:
ppublish
Résumé
To describe the frequency, content, dynamics, and patterns of cost conversations in academic medical oncology across tumor types. We reviewed 529 audio recordings between May 3, 2012, to September 23, 2014, from a prospective three-site communication study in which patients at any stage of management for any solid tumor malignancy were seen in routine oncology appointments. Recordings were deidentified, transcribed, and flagged for any mention of cost. We coded encounters and used qualitative thematic analysis. Financial issues were discussed in 151 (28%) of 529 recordings. Conversations lasted shorter than 2 minutes on average. Patients/caregivers raised a majority of discussions (106 of 151), and 40% of cost concerns raised by patients/caregivers were not verbally acknowledged by clinicians. Social service referrals were made only six times. Themes from content analysis were related to insurance eligibility/process, work insecurity, cost of drugs, cost used as tool to influence medical decision making, health care-specific costs, and basic needs. Financial concerns influenced oncology work processes via test or medication coverage denials, creating paperwork for clinicians, potentially influencing patient involvement in trials, and leading to medication self-rationing or similar behaviors. Typically, financial concerns were associated with negative emotions. Financial issues were raised in approximately one in four academic oncology visits. These brief conversations were usually initiated by patients/caregivers, went frequently unaddressed by clinicians, and seemed to influence medical decision making and work processes and contribute to distress. Themes identified shed light on the kinds of gaps that must be addressed to help patients with cancer cope with the rising cost of care.
Identifiants
pubmed: 31162996
doi: 10.1200/JOP.18.00618
pmc: PMC6804867
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e690-e703Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL128859
Pays : United States
Organisme : NCCIH NIH HHS
ID : R01 AT006515
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States
Références
Am Soc Clin Oncol Educ Book. 2017;37:35-39
pubmed: 28561659
J Natl Compr Canc Netw. 2016 May;14(5 Suppl):616-9
pubmed: 27226499
J Oncol Pract. 2017 Nov;13(11):e944-e956
pubmed: 28834684
Ann Oncol. 2010 Sep;21(9):1910-1914
pubmed: 20332139
Oncologist. 2015 Oct;20(10):1199-204
pubmed: 26330457
J Clin Oncol. 2014 Feb 1;32(4):306-11
pubmed: 24366936
Med Care. 2012 Nov;50 Suppl:S28-34
pubmed: 23064274
J Clin Oncol. 2007 Jan 10;25(2):233-7
pubmed: 17210946
Am J Manag Care. 2018 Mar;24(5 Suppl):S74-S79
pubmed: 29620814
Am J Manag Care. 2015 Sep;21(9):607-15
pubmed: 26618364
J Clin Oncol. 2016 Aug 20;34(24):2925-34
pubmed: 27247218
Health Aff (Millwood). 2013 Jun;32(6):1143-52
pubmed: 23676531
J Clin Oncol. 2009 Aug 10;27(23):3868-74
pubmed: 19581533
J Natl Cancer Inst. 2011 Jan 19;103(2):117-28
pubmed: 21228314
J Clin Oncol. 2017 Nov 1;35(31):3618-3632
pubmed: 28892432
J Oncol Pract. 2016 Mar;12(3):e281-8, 247-8
pubmed: 26883407
J Oncol Pract. 2015 Jul;11(4):308-12
pubmed: 26015459
BMC Cancer. 2013 Oct 04;13:455
pubmed: 24093624
BMC Health Serv Res. 2015 Nov 25;15:518
pubmed: 26607435
Eur J Cancer. 2007 Sep;43(13):1983-9
pubmed: 17616456
J Clin Oncol. 2010 Sep 20;28(27):4149-53
pubmed: 20697077
JAMA. 2013 Jul 24;310(4):380-8
pubmed: 23917288
J Oncol Pract. 2009 Sep;5(5):218-9
pubmed: 20856729
J Oncol Pract. 2014 May;10(3):162-7
pubmed: 24839274
J Pain Symptom Manage. 2007 Dec;34(6):628-38
pubmed: 17703910
J Clin Diagn Res. 2015 Mar;9(3):JE01-4
pubmed: 25954636
Am Health Drug Benefits. 2016 Jun;9(4):188-97
pubmed: 27688832